Biotechnology
Company Overview of Genzyme Corporation
Executive Profile
Eric J. Ende M.D.Director, Member of Audit Committee and Member of Risk Oversight Committee, Genzyme Corporation |
| Age | Total Calculated Compensation | This person is connected to 1 Board Members in 1 different organizations across 4 different industries. See Board Relationships |
| 43 | -- |
Background
Dr. Eric J. Ende, M.D. served as Biotechnology Analyst of Merrill Lynch & Co. Inc. Dr. Ende served as an Equity Analyst at Lehman Brothers Holdings Inc., Research Division, Banc of America Securities LLC, Research Division and Research Analyst of BofA Merrill Lynch, Research Division. He has been a Director of Genzyme Corporation since June 2010.
Corporate Headquarters500 Kendall StreetCambridge, Massachusetts 02142 United States Phone: 617-252-7500 Fax: 617-252-7600 Board Members Memberships2010-Present Director, Member of Audit Committee and Member of Risk Oversight Committee
EducationThere is no Education data available.Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Berkeley, CA | BayerPosted: May 17
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
- Miami, FL | Sterling Life SciencesPosted: May 09
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact Genzyme Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
